Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Recommendation of “Moderate Buy” by Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $56.31.

A number of research firms recently issued reports on ACHC. KeyCorp decreased their price target on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, March 3rd. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Barclays downgraded shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. TD Cowen decreased their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Phocas Financial Corp. grew its holdings in Acadia Healthcare by 30.6% in the fourth quarter. Phocas Financial Corp. now owns 94,320 shares of the company’s stock worth $3,740,000 after purchasing an additional 22,095 shares during the period. Public Employees Retirement System of Ohio purchased a new stake in Acadia Healthcare in the fourth quarter worth about $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Acadia Healthcare by 22.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company’s stock worth $12,439,000 after purchasing an additional 56,647 shares during the period. Voloridge Investment Management LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $15,770,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $1,087,000.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC opened at $29.12 on Wednesday. The company has a market cap of $2.71 billion, a price-to-earnings ratio of 9.55, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a 50-day moving average price of $40.93 and a 200-day moving average price of $49.36. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12 month low of $28.09 and a 12 month high of $82.40.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.